NCT04388839: Evolutionary Therapy for Rhabdomyosarcoma
- State
- Under way
- Phase
- Phase 2
- People
- 12 taking part
- Started
- 29 Dec 2020
- Primary completion
- Aug 2026
- Arms
- Arm B - Second Strike - Maintenance
- Results
- None posted
- 14 May 2020: Trial registered
- 29 Dec 2020: Trial started